CITADELRESEARCH MATERIALS

Use code CITADEL10 for 10% off at checkout

Research peptide overview

CJC-1295 (No DAC) / Ipamorelin research

A catalog combination of two peptides with separate growth-hormone-axis research histories.

Terminology

Published sources and researchers may use these names for the same research topic: CJC-1295, CJC 1295, CJC-1295 No DAC, Ipamorelin, CJC Ipamorelin.

Research context

CJC-1295 and ipamorelin are distinct molecules, and the linked sources discuss them separately. The CJC-1295 publication does not characterize Citadel's No DAC catalog variant, and a catalog combination does not establish a combined clinical indication or use.

Published sources

The following sources are supplied as research starting points. Read the original records for methods, population or model, limitations, and author conclusions.

Prolonged stimulation of GH by CJC-1295CJC-1295 research study indexed by PubMed; it does not characterize the No DAC catalog variant. Opens PubMed in a new tab.Ipamorelin, the first selective growth hormone secretagogueIpamorelin pharmacology research indexed by PubMed. Opens PubMed in a new tab.

Citadel product information

Citadel catalog listings describe currently offered research material and strength. Batch documentation is published separately when available and remains tied to the batch it describes.

Browse catalogBrowse documentationRequest a quote

Related research topics

Research information is provided for bibliographic and educational context only. Citadel materials are research use only, not for human or veterinary use, and Citadel does not provide dosing, administration, treatment, prevention, or clinical advice.